Type 2 Diabetes Mellitus in Children.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review summarizing practice guidelines without systematic review methodology.
What was done
Narrative review of clinical screening recommendations, diagnostic criteria, and management approaches (primarily from the American Diabetes Association) for type 2 diabetes mellitus in children and adolescents.
What was found
Screening is recommended starting at age 10 or puberty onset for overweight/obese youth with at least two risk factors. Diagnostic thresholds are: fasting plasma glucose ≥126 mg/dL, 2-hour post-OGTT plasma glucose ≥200 mg/dL, A1C ≥6.5%, or random plasma glucose ≥200 mg/dL with symptoms (polyuria, polydipsia, weight loss). First-line pharmacological treatment is metformin combined with nutrition and exercise counseling. Insulin is indicated for ketosis/ketoacidosis, A1C >9%, or random plasma glucose ≥250 mg/dL. The abstract reports no empirical outcome statistics or comparative effect sizes.
Why it matters
It outlines clear diagnostic and therapeutic thresholds to guide primary care clinicians managing pediatric type 2 diabetes in the context of rising childhood obesity.
Limits
As a narrative review, it reflects clinical guidelines rather than primary experimental data or systematic synthesis. The abstract provides no quantitative data on treatment efficacy, adherence rates, or long-term clinical outcomes.
Cited by
- supports A fasting blood glucose level over 125 mg/dL is one of the diagnostic criteria for diabetes.